Health & Pharm General

Regeneus Ltd (ASX:RGS) Japanese Biotech Fund takes up all Rights Issue Shortfall

🕔11/19/2019 10:40:44 AM

Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, has placed the full shortfall of 9,437,872 shares under its recent Non-Renounceable Rights Issue. The shortfall was placed to a Japan-based institutional investor at an issue price of A$0.08 per share for a total of A$755,029.

Read Full Article

Anatara Lifsciences Ltd (ASX:ANR) CEO Steve Lydeamore To Present at the Pitt Street Research Life Sciences Conference

🕔11/18/2019 1:17:55 PM

Anatara's CEO Steve Lydeamore has been invited to present at the Pitt Street Research Life Sciences Conference on the 28th November in Sydney. Any investors interested in attending these presentations are invited to reach out.

Read Full Article

FINANCE VIDEO: Anatara Lifesciences Ltd (ASX:ANR) Interview with CEO Steve Lydeamore

🕔11/15/2019 7:46:07 AM

Anatara Lifesciences Ltd (ASX:ANR) CEO Steve Lydeamore is interviewed by ABN Newswire, and talks about the human trials as well as the product pipeline for next year.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Chairman's Address and AGM Presentation

🕔11/11/2019 11:29:07 AM

As Anatara moves forward, the Board is confident in the knowledge that a substantial market opportunity for Detach(R) remains, with more pressure than ever on producers to reduce their antibiotic use and find suitable alternatives which minimise illnesses, such as scour, on farms.

Read Full Article

Cann Global Limited (ASX:CGB) T12 Food Division Update

🕔11/11/2019 8:34:56 AM

The Food management team at T12, are proud to announce the release of our new and nutritious 'Black Label' Hemp Seed Oil and Hemp Seed mixes product range for the discerning Australian and Asian consumer.

Read Full Article

Cann Global Limited (ASX:CGB) Institutional Investment to Support Expansion

🕔11/5/2019 9:46:44 AM

Cann Global Ltd (ASX:CGB) is pleased to advise that the Company has secured further institutional support from New York based L1 Capital Global Opportunities Master Fund ("L1" or "Investor"). The Company has agreed to issue 2,600,000 secured convertible notes (Notes) to raise $2.22M after costs.

Read Full Article

Cann Global Limited (ASX:CGB) September Quarterly Report

🕔11/1/2019 8:08:16 AM

Cann Global Limited (ASX:CGB) presents its Quarterly report for the three months ended 30 September 2019.

Read Full Article